Volume 79, Number 11, September 11, 2012
About this course
- Released: 09/10/2012
- Expires: 09/11/2014
Learning Objectives:
Upon completion of the article by Schmitt et al, the participant should be able to:
• Summarize the main clinical features of anti-NMDA receptor encephalitis
• Describe the extreme delta brush pattern seen in some patients with anti-NMDA receptor encephalitis in this report
• Discuss the findings from this study regarding clinical differences between the patients with anti-NMDA receptor encephalitis with the extreme delta brush pattern compared to those without this EEG pattern
• Consider anti-NMDA receptor encephalitis in patients with this unusual EEG pattern
Core Competencies:
The article by Schmitt et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Lu et al, the participant should be able to:
• State the current US Food and Drug Administration (FDA) pregnancy risk category classifications of the disease-modifying drugs for multiple sclerosis
• Discuss the findings from this review assessing the perinatal or developmental outcomes in offspring of men or women who were taking disease-modifying drugs for multiple sclerosis
• State the recommendations from this study regarding pregnancy and the use of disease-modifying drugs for multiple sclerosis
Core Competencies:
The article by Lu et al covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
